Insilico Medicine and Bora Pharmaceuticals announced a strategic alliance on July 14, 2026 worth up to $2.5 billion, aiming to extend Insilico's generative AI platform Pharma.AI from drug discovery into pharmaceutical manufacturing and quality operations.
Aerial photography analysis reported by Electrek on August 12, 2026 found nearly 1,000 Waymo Ojai robotaxis staged at the company's Arizona factory as weekly paid rides approach 500,000, part of a buildup toward a 1-million-ride weekly target and expansion into more than 20 new cities.
NIH researchers presenting at NUTRITION 2026 found four popular AI photo-based calorie-tracking apps underestimated meals by 250 to 345 calories on average, using a controlled metabolic kitchen to test MyFitnessPal, LoseIt!, CalAI, and Appediet against precisely measured meals.
Twelve major U.S. health systems, serving nearly 20 million patients a year, announced on August 11, 2026 that they are forming a Diagnostic AI Consortium with Aidoc to test and share AI-enabled diagnostic workflows amid a worsening radiologist shortage.
A Hong Kong University of Science and Technology-led team published a Nature Cancer study on an AI system called PRET that recognizes 18 cancer types from as few as one to eight slides, beating 11 human pathologists on lymph node metastasis detection, 98.71% AUC versus 81% average accuracy.
Mount Sinai's Tisch Cancer Center launched PRISM, an AI platform built on Triomics' OncoLLM, in January 2026 to match cancer patients across its entire six-hospital network with clinical trials, not just at its main Manhattan campus.
A Mayo Clinic AI model called REDMOD detected 73% of pancreatic cancers a median of 16 months before diagnosis by re-analyzing CT scans radiologists had called normal, according to a study published in Gut.
A JAMA Network Open study of over 6,700 radiologists in China found frequent AI diagnostic tool use is linked to higher, not lower, burnout risk, especially among radiologists with heavy workloads, challenging assumptions about AI easing clinician strain.
The CDC's Center for Forecasting and Outbreak Analytics is using AI-enhanced surveillance to assess both a Bundibugyo Ebola virus outbreak in the DRC and an Andes virus cluster aboard a cruise ship, building on research showing such systems can detect outbreaks up to 24 days earlier.
Bayer has signed a three-year deal with Amsterdam startup Cradle to embed generative AI into its antibody pipeline, aiming to cut optimization cycles and speed higher-quality biologics toward the clinic.